STOCKHOLDERS EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

STOCKHOLDERS' EQUITY

Schedule of share-based compensation

	For The Years Ended December 31,
	2024		2023
Share-based compensation expense:
Stock options	$	219,968	$	-
RSUs	$	348,620	$	-
Total share-based compensation expense	$	568,588	$	-

Schedule of Stock options

	For The Year Ended
Grant-Date Weighted-Average Assumptions	December 31, 2024
Expected term (in years)		4.5
Risk-free interest rate		4.3%
Expected dividend yield		0.0%
Expected volatility		136.0%
Fair value per share of options granted	$	0.18

					Weighted-Average
			Weighted-Average		Remaining		Aggregate
			Exercise Price		Contractual		Intrinsic
	Shares		Per Share		Term (in years)		Value
Options outstanding, December 31, 2023		-		-		-		-
Granted		4,330,000	$	0.23		-		-
Exercised		-		-		-		-
Forfeited		-		-		-		-
Expired		-		-		-		-
Options outstanding, December 31, 2024		4,330,000	$	0.23		3.7	$	6,652,700
Nonvested options, December 31, 2024		4,257,500	$	0.23		3.6	$	6,547,800
Vested and exercisable options, December 31, 2024		72,500	$	0.32		9.6	$	104,900

Schedule of Restricted stock units

				Weighted-Average
				Grant-Date
				Fair Value
	Shares			Per Share
Nonvested shares at December 31, 2023		-			n/a
Granted		2,890,000		$	0.24
Vested		(800,000	)	$	0.22
Forfeited		-			n/a
Nonvested shares at December 31, 2024		2,090,000		$	0.24

Schedule of Common Stock Warrants

	Number of			Weighted Average
	warrants			Exercise Price
Balance outstanding at December 31, 2023 and 2022		12,346,215		$	0.75
Exercised		(2,204,000	)		0.67
Balance outstanding at December 31, 2024		10,142,215		$	0.77

Schedule Of Warrants outstanding

Number of warrants		Exercise Price		Expiration Date	Remaining life (years)
	2,085,715	$	0.46	1/27/2026		1.07
	7,250,000	$	0.85	8/3/2026		1.59
	806,500	$	0.85	2/1/2026		1.09
	10,142,215